633 related items for PubMed ID: 11379808
21. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
Aubier M, Wettenger R, Gans SJ.
Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
[Abstract] [Full Text] [Related]
22. Switch to non-CFC inhaled corticosteroids: a comparative efficacy study of HFA-BDP and CFC-BDP metered-dose inhalers.
Demedts M, Cohen R, Hawkinson R.
Int J Clin Pract; 1999 Mar; 53(5):331-8. PubMed ID: 10695095
[Abstract] [Full Text] [Related]
23. Clinical efficacy and safety of fluticasone propionate 1 mg per day administered via a HFA 134a pressurized metered dose inhaler to patients with moderate to severe asthma. International study group.
Perruchoud AP, Lundback B, Yigla M, Sykes AP.
Respir Med; 2000 Jun; 94 Suppl B():S35-41. PubMed ID: 10919684
[Abstract] [Full Text] [Related]
24. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant.
Busse WW, Brazinsky S, Jacobson K, Stricker W, Schmitt K, Vanden Burgt J, Donnell D, Hannon S, Colice GL.
J Allergy Clin Immunol; 1999 Dec; 104(6):1215-22. PubMed ID: 10589004
[Abstract] [Full Text] [Related]
25. Clinical efficacy and safety of fluticasone propionate 250 microg twice daily administered via a HFA 134a pressurized metered dose inhaler to patients with mild to moderate asthma. French study group.
Tonnel AB, Bons J, Legendre M, Prud'Homme A, Bugnas B, Evano-Celli I, Stuart AM.
Respir Med; 2000 Jun; 94 Suppl B():S29-34. PubMed ID: 10919683
[Abstract] [Full Text] [Related]
26. A new HFA-134a propellant in the administration of inhaled BDP via the Jet spacer: controlled clinical trial vs the conventional CFC.
Vondra V, Sladek K, Kotasová J, Terl M, Rossetti A, Cantini L.
Respir Med; 2002 Oct; 96(10):784-9. PubMed ID: 12412977
[Abstract] [Full Text] [Related]
27. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.
Anderson PB, Langley SJ, Mooney P, Jones J, Addlestone R, Rossetti A, Cantini L.
J Investig Allergol Clin Immunol; 2002 Oct; 12(2):107-13. PubMed ID: 12371526
[Abstract] [Full Text] [Related]
28. Acute safety of beclomethasone dipropionate in a new CFC-free propellant system in asthmatic patients.
Ayres JG, Simmons JL, Stampone P.
Respir Med; 1999 Jan; 93(1):27-32. PubMed ID: 10464845
[Abstract] [Full Text] [Related]
29. Effects of HFA- and CFC-beclomethasone dipropionate on the bronchial response to methacholine (MCh) in mild asthma.
Micheletto C, Guerriero M, Tognella S, Dal Negro RW.
Respir Med; 2005 Jul; 99(7):850-5. PubMed ID: 15939246
[Abstract] [Full Text] [Related]
30. Comparison of hydrofluoroalkane-beclomethasone dipropionate Autohaler with budesonide Turbuhaler in asthma control.
Worth H, Muir JF, Pieters WR.
Respiration; 2001 Jul; 68(5):517-26. PubMed ID: 11694816
[Abstract] [Full Text] [Related]
31. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.
Vanden Burgt JA, Busse WW, Martin RJ, Szefler SJ, Donnell D.
J Allergy Clin Immunol; 2000 Dec; 106(6):1209-26. PubMed ID: 11112914
[Abstract] [Full Text] [Related]
32. Equivalent asthma control after dose reduction with HFA-134a beclomethasone solution aerosol. Comparative Inhaled Steroid Investigation Group (CISIG).
Magnussen H.
Respir Med; 2000 Jun; 94(6):549-55. PubMed ID: 10921758
[Abstract] [Full Text] [Related]
33. Effectiveness of low doses (50 and 100 microg b.i.d) of beclomethasone dipropionate delivered as a CFC-free extrafine aerosol in adults with mild to moderate asthma. Study Group.
Hampel F, Lisberg E, Guérin JC.
J Asthma; 2000 Aug; 37(5):389-98. PubMed ID: 10983616
[Abstract] [Full Text] [Related]
34. Inhaled beclomethasone (BDP) with non-CFC propellant (HFA 134a) is equivalent to BDP-CFC for the treatment of asthma.
Milanowski J, Qualtrough J, Perrin VL.
Respir Med; 1999 Apr; 93(4):245-51. PubMed ID: 10464888
[Abstract] [Full Text] [Related]
35. Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma.
Tatsis G, Kotsifas K, Filaditaki V, Makrantoni G, Boulia S.
J Int Med Res; 2007 Apr; 35(3):361-73. PubMed ID: 17593865
[Abstract] [Full Text] [Related]
36. Clinically important improvements in asthma-specific quality of life, but no difference in conventional clinical indexes in patients changed from conventional beclomethasone dipropionate to approximately half the dose of extrafine beclomethasone dipropionate.
Juniper EF, Price DB, Stampone PA, Creemers JP, Mol SJ, Fireman P.
Chest; 2002 Jun; 121(6):1824-32. PubMed ID: 12065345
[Abstract] [Full Text] [Related]
37. The cost effectiveness of chlorofluorocarbon-free beclomethasone dipropionate in the treatment of chronic asthma: a cost model based on a 1-year pragmatic, randomised clinical study.
Price D, Haughney J, Duerden M, Nicholls C, Moseley C.
Pharmacoeconomics; 2002 Jun; 20(10):653-64. PubMed ID: 12162754
[Abstract] [Full Text] [Related]
38. Efficacy of chlorofluorocarbon-free beclomethasone dipropionate 400 micrograms day-1 delivered as an extrafine aerosol in adults with moderate asthma.
Matthys H, Nowak D, Hader S, Kunkel G.
Respir Med; 1998 Jun; 92 Suppl A():17-22. PubMed ID: 9850359
[Abstract] [Full Text] [Related]
39. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
Fairfax A, Hall I, Spelman R.
Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
[Abstract] [Full Text] [Related]
40. Extra-fine particles improve lung delivery of inhaled steroids in infants: a study in an upper airway model.
Janssens HM, De Jongste JC, Hop WC, Tiddens HA.
Chest; 2003 Jun; 123(6):2083-8. PubMed ID: 12796192
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
